Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV.
about
Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge.HIV vaccine acceptability among communities at risk: the impact of vaccine characteristicsHIV related high risk behaviors and willingness to participate in HIV vaccine trials among China MSM by computer assisted self-interviewing survey.Differences in HIV vaccine acceptability between genders.Endorsement of compulsory HIV vaccination policy among populations at high risk of HIV exposure (LA VOICES).HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approachHIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysisAcceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.Willingness to receive an HIV vaccine among incarcerated personsWillingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in UgandaAnticipated HIV Vaccine Acceptability among Sexually Active African-American Adult Women.Use of conjoint analysis to assess HIV vaccine acceptability: feasibility of an innovation in the assessment of consumer health-care preferences.Explaining the Efficacy of Pre-exposure Prophylaxis (PrEP) for HIV Prevention: A Qualitative Study of Message Framing and Messaging Preferences Among US Men Who have Sex with Men.Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example.Anticipated changes in sexual risk behaviour following vaccination with a low-efficacy HIV vaccine: survey results from a South African township.Perceptions of sexual risk compensation following posttrial HIV vaccine uptake among young South Africans.What can HIV vaccine trials teach us about future HIV vaccine dissemination?Racial/ethnic differences in trust in health care: HIV conspiracy beliefs and vaccine research participation.Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES).Using conjoint analysis to measure the acceptability of rectal microbicides among men who have sex with men in four South American cities.Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City.A small dose of HIV? HIV vaccine mental models and risk communication.Local understanding of an HIV vaccine and its relationship with HIV-related stigma in the Dominican Republic.'Why would you promote something that is less percent safer than a condom?': Perspectives on partially effective HIV prevention technologies among key populations in South Africa
P2860
Q25255907-1E38BCF4-10C9-4739-8E86-69447BD011EEQ30352116-9ED5C14A-1746-4CE5-BCC3-EB1DBB487DA6Q30357307-A6A65381-C9EF-4B0E-8AF5-180F7177370CQ30369465-FF53452E-4522-4DE5-B4DB-6107A4C2C32BQ33638974-743E8265-7586-446F-B46C-5DAF507CF277Q33689222-48C8CA9A-1908-427B-9DA4-C274D8E2EA45Q33786360-3EAB2CEB-8D77-40FE-BC8D-176F6D7A45B0Q34786117-3D4803C1-63AA-4E47-AC47-33766BD6FB08Q34989216-DA0006A6-3356-48A0-844F-70DF33F9652AQ35644871-096AABC2-AD72-4B53-AAAC-9576D09258C6Q35863340-C12A8452-6D66-4A16-8F77-EB2361B2EB5CQ35890620-662C2D11-5B9C-4E1B-8084-049183B6A94EQ36022717-5E3E7ED4-A839-4BCE-AB9E-5076C733A8A8Q36276035-7F64662B-4D08-47FE-A1AD-FAB7A82FEA06Q36603971-3CA968BF-8C70-4855-9F43-1B527930B0D7Q36975561-FADCAE32-0D3D-4492-BBFF-CBC81530EA11Q37075094-116B4420-7BA0-41F6-AE95-5D43481D3682Q37274924-B47B7C05-602A-4EA2-A910-3AA48199D306Q37471381-F57D5886-D190-4DEB-8237-400F73407426Q37485276-B5191F4A-7C30-406E-9F12-4A2DA0B8E883Q40001039-2EA34FDC-A06A-4CC0-8C28-7378E9335990Q40127795-20A919C3-DD6F-4DF3-9498-FA200454FF29Q40151338-C9C6B2BA-9883-4FF9-BEB3-B6B0D711E05FQ51741021-A67B3D4A-CCF7-48CA-9FE4-4C792ACCD5F5Q58452343-ACAECD3C-6C1D-46F8-AC6E-9A3191C4A630
P2860
Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Posttrial HIV vaccine adoption ...... among persons at risk for HIV.
@ast
Posttrial HIV vaccine adoption ...... among persons at risk for HIV.
@en
type
label
Posttrial HIV vaccine adoption ...... among persons at risk for HIV.
@ast
Posttrial HIV vaccine adoption ...... among persons at risk for HIV.
@en
prefLabel
Posttrial HIV vaccine adoption ...... among persons at risk for HIV.
@ast
Posttrial HIV vaccine adoption ...... among persons at risk for HIV.
@en
P2093
P1476
Posttrial HIV vaccine adoption ...... among persons at risk for HIV.
@en
P2093
Ellen T Rudy
Kathleen J Roberts
Naihua Duan
P304
P356
10.1097/01.QAI.0000127064.84325.AD
P407
P577
2004-11-01T00:00:00Z